Page URL: https://www.bionews.org.uk/page_152787

Protein delivered to testes improves sperm production

26 October 2020
Appeared in BioNews 1069

Scientists have directly delivered proteins to mouse testes for the first time, in an attempt to treat male infertility.

The team of researchers from Seoul National University, South Korea, successfully delivered an important protein, necessary for sperm production, into the testes of infertile mice and restored normal reproductive function.

Infertility affects around 15 percent of couples worldwide, with male infertility thought to be linked to anywhere between 20-70 percent of these cases. Damage to the blood-testis barrier (BTB), which normally protects sperm cells from any harmful substances within the blood, is one cause of reduced sperm production.

Although gene therapy has the potential to correct defects underlying male infertility, there remains a number of safety and ethical concerns. The adverse long-term effects of genome editing of germ cells and risk to future generations remain unknown.

In the current study, published in ACS Nano, the scientists developed an alternative approach, using nanoparticles to directly deliver proteins to the testes. The delivery system, called Fibroplex, consisted of spherical nanoparticles made of silk fibroin, which were coated in lipids.

The Fibroplex was loaded with a protein required for normal function of the BTB, known as PIN1. The entire complex was then injected into the testes of young male mice which had been genetically engineered to lack the PIN1 protein, making them infertile.

The scientists found that Fibroplex safely delivered the PIN1 protein to the mouse testes and did not lead to any toxicity or testicular damage. The treatment increased sperm stem cell numbers and repaired the BTB. In addition, the treated mice had an increased number of mature sperm. Although the sperm count was still only around half of that of normal fertile mice, the treated mice were able to father a similar number of pups, whilst untreated PIN1-deficient mice were unable to reproduce.

The beneficial effects of the treatment lasted for approximately five months, after which the PIN1 protein degraded.

Further studies are now needed in order for scientists to understand whether this approach may be an effective strategy for treating infertility in humans.

SOURCES & REFERENCES
Delivering proteins to testes could someday treat male infertility
ACS Chemistry of Life |  21 October 2020
Intratesticular peptidyl prolyl isomerase 1 protein delivery using cationic lipid-coated fibroin nanoparticle complexes rescues male infertility in mice
ASC Publications |  24 September 2020
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
2 November 2020 - by Jen Willows 
Even a small increase in temperature during sperm production can amplify DNA damage, new research suggests...
12 October 2020 - by Laura Riggall 
Men who recover from moderate or severe COVID-19 symptoms may have reduced fertility, a new study has claimed...
12 October 2020 - by Jennifer Frosch 
A single-measure biomarker in sperm could replace traditional measures of male fertility, study shows...
27 July 2020 - by Charlott Repschlager 
Mutations in the M1AP gene have been identified by researchers as a major trigger for male infertility...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.